Completed
Pharmacological Treatment for Alcoholism
Led by National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Updated on 2005-06-24
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.
CONDITIONS
Official Title
Ondansetron Treatment for Alcoholism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet criteria for alcohol dependence.
- Subjects with early onset alcoholism must also have a diagnosis of antisocial personality disorder.
- Understand the requirements of the study and be able to complete the questionnaires and rating scales.
You will not qualify if you...
- Current diagnosis of substance dependence or self-report of having used narcotics (opiates, cocaine, amphetamine-like substances, and hallucinogens) in the 30 day period prior to study.
- Positive urine drug screen test for narcotics, barbiturates, or benzodiazepines.
- Receiving current psychotropic medications.
- Current history of other psychiatric disorders excluding nicotine dependence.
- Hepatocellular disease.
- Pregnant females.
Trial Site Locations
Total: 1 location
1
Substance Abuse Research Center, University of Texas Health Science Center
Houston, Texas, United States, 77030
Status Unknown
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here